We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Integrating Bispecific Antibodies Into Clinical Practice
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Rhonda Cadena, MD, FNCS, FCCM
Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
Stuart Connolly, MD, FRCPC
Greg Albers, MD
Optimizing ICH Care By Leveraging AC Reversal, AI & Care Bundling
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)
Annie Levesque, MD, MSc
Ethan A. Cowan, MD
The Path Forward: What’s On The Horizon?
Manesh R. Patel, MD
Questions & Answers from the AHA 2023 Symposium
M. Cecilia Bahit, MD
Elaine Hylek, MD, MPH
While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?
The DOAC Revolution: What Have We Learned?
Christopher B. Granger, MD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education